Innova Captab Ltd
Fri 7/11/2025,15:58:0 | NSE : INNOVACAP
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 800.00
Previous Close
₹ 802.95
Volume
73588
Mkt Cap ( Rs. Cr)
₹4392.01
High
₹ 806.60
Low
₹ 761.90
52 Week High
₹ 1260.00
52 Week Low
₹ 662.00
Book Value Per Share
₹ 167.66
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Innova Captab Ltd
Your Vote -
Buy
60.00%
Hold
0.00%
Sell
40.00%
60.00%
10 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
767.50
70
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
70
Option Chain
Analyzes market sentiment, predicts Innova Captab Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Innova Captab - Press Release
-
Innova Captab - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Innova Captab - Investor Presentation
-
Innova Captab - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Innova Captab - Approval Of The Unaudited (Standalone And Consolidated) Financial Results For The Quarter And Half Year Ended
-
Innova Captab - Updates
-
Innova Captab - Mr. Devendra Ganpatrav Palav, Who Currently Serves As The Chief Executive Officer (CEO) Of Sharon Bio-Medicin
-
Innova Captab Q2 net profit down 44.05% at Rs 14.33 cr
-
Innova Captab - Outcome of Board Meeting
-
Innova Captab - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. 07Th November, 2025
-
Innova Captab - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates
-
Innova Captab - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (LODR)Regulations, 2
-
Innova Captab - Recommendation Of GMP Compliance Certificate By The State Service Of Ukraine On Medicines And Drugs Control.
-
Innova Captab - Updates
-
Innova Captab - Updates
-
Innova Captab - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure
-
Innova Captab has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Innova Captab - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Innova Captab - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Innova Captab - Trading Window
-
Innova Captab - Pursuant To Regulation 30 Read With Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requir
-
Innova Captab - Credit Rating- Revision
-
Innova Captab - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure
-
Innova Captab - Agreements
-
Innova Captab - Pursuant To The Regulation 30 (Read With Part A Of Schedule III) And Other Applicable Provisions Of SEBI (Lis
-
Innova Captab - General Updates
-
Innova Captab - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Innova Captab - Analysts/Institutional Investor Meet/Con. Call Updates
Key fundamentals
Evaluate the intrinsic value of Innova Captab Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 1140.093 | 964.502 | 503.507 | 386.882 | 184.247 |
| Liabilities | 1140.093 | 964.502 | 503.507 | 386.882 | 184.247 |
| Equity | 57.225 | 57.225 | 48 | 12 | 12 |
| Gross Profit | 122.299 | 107.97 | 98.529 | 98.509 | 54.486 |
| Net Profit | 89.47 | 68.161 | 57.552 | 66.178 | 34.5 |
| Cash From Operating Activities | 19.801 | 111.674 | 39.279 | 58.339 | 41.564 |
| NPM(%) | 9.33 | 7.88 | 6.7 | 8.42 | 8.4 |
| Revenue | 958.061 | 864.929 | 858.673 | 785.455 | 410.662 |
| Expenses | 835.762 | 756.959 | 760.144 | 686.946 | 356.176 |
| ROE(%) | 9.32 | 7.1 | 5.99 | 6.89 | 3.59 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Innova Captab Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 857.15 | -1.60 | 77.71 | 438.17 | 301.39 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 121.23 | -1.62 | 391.06 | 1596.64 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 9.74 | -1.02 | 324.67 | 10016.23 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 632.75 | -1.73 | 0.00 | 1505.66 | -604.77 | 0.00 |
Company Info
Theompany wasincorporated in Mumbai, Maharashtra, as`Harun Health Care Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 3, 2005, issued by the RoC. Thereafter, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on December 26, 2009, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', in order to reflect innovations in the pharmaceutical sector. Consequently, a fresh certificate of incorporation dated February 2, 2010, was issued by the RoC to the Company. Subsequently, the Company was converted from a private limited company to a public limited company, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on July 12, 2018, and consequently, the name of the Company was changed to the present name `Innova Captab Limited', and a fresh certificate of incorporation dated July 26, 2018, was issued by the RoC to the Company.Major events and milestones of the Company :2006- stablished the first manufacturing plant in Baddi, Himachal Pradesh2010- Changed the name of the Company from `Harun Health Care Private Limited' to `Innova Captab Private Limited'- Commenced operations at the cephalosporin block of the plant in Baddi, Himachal Pradesh2013- Crossed ?500.00 million in total revenue- Received the first international accreditation in the form of certificate of good manufacturing practices ("GMP") for all manufacturing activities of the Company in relation to the cephalosporin products from the Ministry of Medical Services, Republic of Kenya2015- Incorporated Univentis Medicare Limited through which we undertake the marketing operations2018- Converted the Company from a private limited company to a public limited company2019- Crossed ?3,000.00 million in total revenue2021- Leased land to establish industrial plant at Samba, Jammu and Kashmir- Acquired land to build state of art research and development centre in Panchkula, Haryana- Acquired the assets and liabilities of Innova Partnership on going concern through slump sale- Acquired Univentis Medicare Limited as a wholly owned subsidiary2023- Acquisition of Sharon Bio-Medicine Limited through the wholly owned subsidiary Univentis Medicare Limited.
Theompany wasincorporated in Mumbai, Maharashtra, as`Harun Health Care Private Limited', a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 3, 2005, issued by the RoC. Thereafter, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on December 26, 2009, the name of the Company was changed from `Harun Health Care Private Limited' to `Innova Captab Private Limited', in order to reflect innovations in the pharmaceutical sector. Consequently, a fresh certificate of incorporation dated February 2, 2010, was issued by the RoC to the Company. Subsequently, the Company was converted from a private limited company to a public limited company, pursuant to a resolution passed by the Shareholders in the extraordinary general meeting held on July 12, 2018, and consequently, the name of the Company was changed to the present name `Innova Captab Limited', and a fresh certificate of incorporation dated July 26, 2018, was issued by the RoC to the Company.Major events and milestones of the Company :2006- stablished the first manufacturing plant in Baddi, Himachal Pradesh2010- Changed the name of the Company from `Harun Health Care Private Limited' to `Innova Captab Private Limited'- Commenced operations at the cephalosporin block of the plant in Baddi, Himachal Pradesh2013- Crossed ?500.00 million in total revenue- Received the first international accreditation in the form of certificate of good manufacturing practices ("GMP") for all manufacturing activities of the Company in relation to the cephalosporin products from the Ministry of Medical Services, Republic of Kenya2015- Incorporated Univentis Medicare Limited through which we undertake the marketing operations2018- Converted the Company from a private limited company to a public limited company2019- Crossed ?3,000.00 million in total revenue2021- Leased land to establish industrial plant at Samba, Jammu and Kashmir- Acquired land to build state of art research and development centre in Panchkula, Haryana- Acquired the assets and liabilities of Innova Partnership on going concern through slump sale- Acquired Univentis Medicare Limited as a wholly owned subsidiary2023- Acquisition of Sharon Bio-Medicine Limited through the wholly owned subsidiary Univentis Medicare Limited.
Read More
Parent Organisation
Innova Captab Ltd.
Founded
03/01/2005
Managing Director
Mr.Vinay Kumar Lohariwala
NSE Symbol
INNOVACAPEQ
FAQ
The current price of Innova Captab Ltd is ₹ 767.50.
The 52-week high for Innova Captab Ltd is ₹ 806.60 and the 52-week low is ₹ 761.90.
The market capitalization of Innova Captab Ltd is currently ₹ 4392.01. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Innova Captab Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Innova Captab Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Innova Captab Ltd shares.
The CEO of Innova Captab Ltd is Mr.Vinay Kumar Lohariwala, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
